
PMC:7381711 / 2984-3953
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T17 | 0-7 | Body_part | denotes | Heparin | http://purl.org/sig/ont/fma/fma82839 |
T18 | 71-86 | Body_part | denotes | heparan sulfate | http://purl.org/sig/ont/fma/fma63023 |
T19 | 88-90 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
T20 | 92-110 | Body_part | denotes | glycosaminoglycans | http://purl.org/sig/ont/fma/fma63011 |
T21 | 133-143 | Body_part | denotes | intestines | http://purl.org/sig/ont/fma/fma7199 |
T22 | 197-199 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
T23 | 200-217 | Body_part | denotes | glycosaminoglycan | http://purl.org/sig/ont/fma/fma63011 |
T24 | 233-240 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T25 | 332-339 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T26 | 403-411 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T27 | 457-463 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
T28 | 657-659 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
T29 | 762-769 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T30 | 770-777 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T31 | 930-937 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 133-143 | Body_part | denotes | intestines | http://purl.obolibrary.org/obo/UBERON_0000160 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
97 | 501-504 | Gene | denotes | AT3 | Gene:462 |
98 | 683-686 | Gene | denotes | AT3 | Gene:462 |
99 | 722-725 | Gene | denotes | AT3 | Gene:462 |
100 | 483-499 | Gene | denotes | antithrombin-III | Gene:462 |
101 | 0-7 | Chemical | denotes | Heparin | MESH:D006493 |
102 | 71-110 | Chemical | denotes | heparan sulfate (HS) glycosaminoglycans | |
103 | 197-217 | Chemical | denotes | HS glycosaminoglycan | |
104 | 233-240 | Chemical | denotes | heparin | MESH:D006493 |
105 | 332-339 | Chemical | denotes | heparin | MESH:D006493 |
106 | 457-463 | Chemical | denotes | serine | MESH:D012694 |
107 | 618-633 | Chemical | denotes | pentasaccharide | |
108 | 762-769 | Chemical | denotes | heparin | MESH:D006493 |
109 | 930-937 | Chemical | denotes | heparin | MESH:D006493 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 11-12 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 133-143 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestines |
T10 | 133-143 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestines |
T11 | 538-546 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T12 | 567-575 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T13 | 608-609 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 818-821 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T21 | 0-7 | Chemical | denotes | Heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T22 | 71-86 | Chemical | denotes | heparan sulfate | http://purl.obolibrary.org/obo/CHEBI_28815 |
T23 | 71-78 | Chemical | denotes | heparan | http://purl.obolibrary.org/obo/CHEBI_24500 |
T24 | 79-86 | Chemical | denotes | sulfate | http://purl.obolibrary.org/obo/CHEBI_16189 |
T25 | 88-90 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
T27 | 92-110 | Chemical | denotes | glycosaminoglycans | http://purl.obolibrary.org/obo/CHEBI_18085 |
T28 | 197-199 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
T30 | 200-217 | Chemical | denotes | glycosaminoglycan | http://purl.obolibrary.org/obo/CHEBI_18085 |
T31 | 233-240 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T32 | 332-339 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T33 | 403-411 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T34 | 457-482 | Chemical | denotes | serine protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_64926 |
T35 | 457-463 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T36 | 464-482 | Chemical | denotes | protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T38 | 473-482 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T39 | 524-537 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T40 | 553-566 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T41 | 618-633 | Chemical | denotes | pentasaccharide | http://purl.obolibrary.org/obo/CHEBI_35369 |
T42 | 657-659 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
T44 | 762-769 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T45 | 770-777 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T46 | 930-937 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 524-546 | http://purl.obolibrary.org/obo/GO_0050819 | denotes | anticoagulant activity |
T2 | 553-575 | http://purl.obolibrary.org/obo/GO_0050819 | denotes | anticoagulant activity |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 0-157 | Sentence | denotes | Heparin is a heterogeneous preparation of long, linear highly sulfated heparan sulfate (HS) glycosaminoglycans purified from porcine intestines (see Fig. 1). |
T23 | 158-312 | Sentence | denotes | The sulfated nature of its constituent HS glycosaminoglycan chains confers heparin with the highest negative charge density of any known biomolecule (43). |
T24 | 313-547 | Sentence | denotes | This charge allows heparin to strongly and selectively interact with an immense number of proteins, the most classic being its interaction with serine protease inhibitor antithrombin-III (AT3) that provides its anticoagulant activity. |
T25 | 548-714 | Sentence | denotes | This anticoagulant activity is dependent on the presence of a precise pentasaccharide sequence within longer HS chains that allows for AT3 binding as shown in Fig. 1. |
T26 | 715-969 | Sentence | denotes | Beyond AT3, hundreds of biologically relevant, heparin-protein interactions have been described, which has led to the recognition of an immense number of potential off-target (both positive and negative) effects of heparin of unknown clinical importance. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 71-86 | GlycoEpitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T2 | 88-90 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T3 | 197-199 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T4 | 657-659 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32519894-28653068-2138150 | 308-310 | 28653068 | denotes | 43 |